Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study


Creative Commons License

Bachet J., Wyrwicz L., Price T., Cremolini C., Phelip J., Portales F., ...Daha Fazla

ESMO OPEN, cilt.5, sa.3, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 5 Konu: 3
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1136/esmoopen-2020-000698
  • Dergi Adı: ESMO OPEN

Özet

Background In RECOURSE (, trifluridine/tipiracil significantly improved overall survival and progression-free survival (PFS) versus placebo in patients with pretreated metastatic colorectal cancer (mCRC). PRECONNECT was designed to further characterise safety and clinical use of trifluridine/tipiracil.